Gene expression of group II phospholipase A2 in intestine in ulcerative colitis

Gut

Volumn 40, Issue 1, 1997, Pages 95-101

  Haapamaki M M ^a   Gronroos J M ^a   Nurmi, H ^a   Alanen, K ^a   Kallajoki, M ^a   Nevalainen, T J ^a  

^a UNIVERSITY OF TURKU   (Finland)

Author keywords

In situ hybridisation; Inflammatory bowel disease; Northern blotting; Phosphalipase A2; Ulcerative colitis

Indexed keywords

PHOSPHOLIPASE A2;

ADULT; ARTICLE; BIOPSY; CLINICAL ARTICLE; COLONOSCOPY; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IN SITU HYBRIDIZATION; MALE; NORTHERN BLOTTING; PATHOGENESIS; PRIORITY JOURNAL; ULCERATIVE COLITIS;

EID: 0031042970     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.40.1.95     Document Type: Article

References (25)

1. Benveniste J, Chignard M, Le Couedic J, Vargaftig B. Biosynthesis of platelet-activating factor (PAF-acether). II. Involvement of phospholipase A2 in the formation of PAF-acether and lyso-PAF-acether from rabbit platelets. Thromb Res 1982; 25: 375-85.
2. Kiyohara H, Egami H, Shibata Y, Murata K, Ohshima S, Ogawa M. Light microscopic immunohistochemical analysis of the distribution of group II phospholipase A2 in human digestive organs. J Histochem Cytochem 1992; 40: 1659-64.
3. Nevalainen TJ, Haapanen TJ. Distribution of pancreatic (group I) and synovial-type (group II) phospholipases A2 in human tissues. Inflammation 1993; 17: 453-64.
4. Vadas P, Browning J, Edelson J, Pruzanski W. Extracellular phospholipase A2 expression and inflammation: the relationship with associated disease states. J Lipid Mediat 1993; 8: 1-30.
5. Nevalainen TJ. Serum phospholipases A2 in inflammatory diseases. Clin Chem 1993; 39: 2453-9.
6. Nevalainen TJ, Grönroos JM, Kortesuo PT. Pancreatic and synovial type phospholipases A2 in serum samples from patients with severe acute pancreatitis. Gut 1993; 34: 1133-6.
7. Grönroos JM, Kuttila K, Nevalainen TJ. Group II phospholipase A2 in serum in critically ill surgical patients. Crit Care Med 1994; 22: 956-9.
8. Minami T, Tojo H, Shinomura Y, Tarui S, Okamoto M. Raised serum activity of phospholipase A2 immunochemically related to group II enzyme in inflammatory bowel disease: its correlation with disease activity of Crohn's disease and ulcerative colitis. Gut 1992; 33: 914-21.
9. Minami T, Tojo H, Shinomura Y, Matsuzawa Y, Okamoto M. Increased group II phospholipase A2 in colonic mucosa of patients with Crohn's disease and ulcerative colitis. Gut 1994; 35: 1593-8.
10. Nevalainen TJ, Grönroos JM, Kallajoki M. Expression of group II phospholipase A2 in the human gastrointestinal tract. Lab Invest 1995; 72: 201-8.
11. Matts SGF. The value of rectal biopsy in the diagnosis of ulcerative colitis. Q J Med 1961; 30: 393-407.
12. Nevalainen TJ, Märki F, Kortesuo PT, Grütter M, DiMarco S, Schmitz A. Synovial type (group II) phospholipase A2 in cartilage. J Rheumatol 1993; 20: 325-30.
13. Hsu SM, Raine L, Fanger H. The use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem 1981; 29: 577-80.
14. Di Marco S, Märki F, Hofstetter H, Schmitz A, van Oostrum J, Grütter MG. Purification, analysis, and enzymatic activity of recombinant human synovial fluid phospholipase A2 and N-terminal variants. J Biochem 1992; 112: 350-4.
15. Seilhamer JJ, Pruzanski W, Vadas P, Plant S, Miller JA, Kloss J, et al. Cloning and recombinant expression of phospholipase A2 present in rheumatoid arthritic synovial fluid. J Biol Chem 1989; 264: 5335-8.
16. Chirgwin JM, Przybyla AE, MacDonald RJ, Rutter WJ. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 1979; 18: 5294-9.
17. Denhardt DT. A membrane-filter technique for the detection of complementary DNA. Biochem Biophys Res Commun 1966; 23: 641-6.
18. Feinberg AP, Vogelstein BA. Technique for radiolabelling DNA restriction endonuclease fragments to high specific activity. Anal Biochem 1983; 132: 6-13.
19. Kramer RM, Hession C, Johansen B, Hayes G, McGray P, Chow EP, et al. Structure and properties of a human non-pancreatic phospholipase A2. J Biol Chem 1989; 264: 5768-75.
20. Lilja I, Smedh K, Olaison G, Sjodahl R, Tagesson C, Gustafson-Svärd C. Phospholipase A2 gene expression and activity in histologically normal ileal mucosa and in Crohn's ileitis. Gut 1995; 9: 380-5.
21. Pruzanski W, Saito S, Stefanski E, Vadas P. Comparison of group I and II soluble phospholipases A2 activities on phagocytic functions of human polymorphonuclear and mononuclear phagocytes. Inflammation 1991; 15: 127-35.
22. Bomalaski J, Baker DG, Brophy L, Resurreccion NV, Spilberg I, Muniain M, et al. A phospholipase A2-activating protein (PLAP) stimulates human neutrophil aggregation and release of lysosomal enzymes, superoxide, and eicosanoids. J Immunol 1989; 142: 3957-62.
23. Weiss J, Inada M, Elsbach P, Growl RM. Structural determinants of the action against Escherichia coli of a human inflammatory fluid phospholipase A2 in concert with polymorphonuclear leukocytes. J Biol Chem 1994; 269: 26331-7.
24. Wright GC, Weiss J, Kim KS, Verheij H, Elsbach P. Bacterial phospholipid hydrolysis enhances the destruction of Escherichia coli ingested by rabbit neutrophils. Role of cellular and extracellular phospholipases. J Clin Invest 1990; 85: 1925-35.
25. Weinrauch Y, Elsbach P, Madsen L, Foreman A, Weiss J. The potent anti-Staphylococcus aureus activity of a sterile rabbit inflammatory fluid is due to a 14-kD phospholipase A2. J Clin Invest 1996; 97: 250-7.